fast

R112 is an ATP-competitive inhibitor of Syk kinase. Ki=6 nM,IC50=226 nM.

Fast Red RC salt, 97%, is utilized in plant science to detect aminotransferase activity and serves as a marker for phosphatase activity in diagnostic procedures.

Fast garnet GBC sulfate salt, 90% (Azoic diazo No. 4, 90%), is a chromogenic substrate for alkaline phosphatase.

Fast Blue RR Salt is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

Acid red 88 is an anionic dye with potentially useful photocatalytic research applications. Acid red 88 has been used to determine the effect of Au deposition on ZnO photocatalytic activity under visible light. Additionally, the photocatalyst Au-TiO2 was

Epicocconone is a fluorescent compound comes from the fungus epicoccumnigrum.

Linaprazan glurate inhibits both exogenously and endogenously stimulated gastric acid secretion and can be utilized in studies on gastrointestinal inflammatory diseases and peptic ulcer diseases.

lifastuzumAb is a humanized IgG1-like monoclonal antibody against NaPi2b, often coupled with the anti-mitotic agent monomethyl auristatin E, which inhibits cell division by blocking the polymerization of microtubule proteins.

Lifastuzumab vedotin is an antibody-drug conjugate (ADC) that blocks cell division by inhibiting tubulin polymerization, with potential applications in the research of non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC).

Anti-SLC34A2 (Lifastuzumab)-SPDB-DM4 is an antibody-drug conjugate (ADC) composed of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody, Lifastuzumab, linked via SPDB to the tubulin inhibitor DM4. The toxic component and linker of this ADC is sulfo-SPDB-DM4. This compound can be utilized for cancer research.

Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 is an antibody-drug conjugate (ADC) composed of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the SMCC linker and the cytotoxic microtubule inhibitor DM1. The ADC's toxic and linker components are SMCC-DM1. Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 can be used for cancer research.

Anti-SLC34A2 (Lifastuzumab)-McMMAF is an antibody-drug conjugate (ADC) composed of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked to the protective group maleimidocaproyl, and the tubulin inhibitor MMAF. The toxic component and linker in this ADC are McMMAF. Anti-SLC34A2 (Lifastuzumab)-McMMAF can induce apoptosis and is utilized in cancer research.

Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) composed of the human-derived anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the Mc-VC-PAB connector and the topoisomeraseI inhibitor SN38. The ADC's cytotoxic component and linker are Mc-VC-PAB-SN38. This compound is utilized in cancer research.

Sucralose is a non-nutritive artificial sweetener and sugar substitute that stimulates appetite in rodents by activating a conserved neural fasting response.

Fexofenadine hydrochloride (Terfenidine carboxylate hydrochloride) is a second generation antihistamine that is used for the treatment of allergic rhinitis, angioedema and chronic urticaria.

Fexofenadine (Carboxyterfenadine), an antihistamine pharmaceutical drug, is used to treat allergy symptoms, such as nasal congestion, hay fever, and urticaria. Compared to first-generation antihistamines, Fexofenadine is less able to pass the blood-brain barrier and cause sedation.

Diclofenac Potassium (CGP-45840B) is a nonsteroidal anti-inflammatory drug taken to reduce inflammation and as an analgesic reducing pain in certain conditions.

Cirsilineol (Eupatrin) is isolated from the herb of Artemisia vestita Wall and shows immunosuppressive, anti-proliferative, and anti-tumor properties. Cirsilineol selectively induces apoptosis via the mitochondrial pathway.

7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.

Acrinathrin is a pyrethroid used as an insecticide and an acaricide. Although resistance is developing, Acrinathrin is used to control the mite Varroa jacobsoni in beekeeping.

polysachoride of Astragalus mongholicus is a natural product that can be used in related research in the field of life sciences. Its product number is TN8875.

Daraxonrasib (RMC-6236) is an orally effective and novel triple complex RAS (ON) MULTI inhibitor, which is a potent non covalent inhibitor of multiple RAS variants in GTP binding state. RMC-6236 has anti-tumor activity and can be used in research related to RAS driven tumors. With rich experience in compound synthesis, we can provide fast customized synthesis services for this product according to your research needs.

Zoldonrasib (RMC-9805) is a mutant-selective covalent KRAS G12D inhibitor with oral activity and significant antitumor activity, inducing tumor cell apoptosis in preclinical models of various KRAS-mutant cancers.

JNJ-37822681 has potential for the treatment of schizophrenia and bipolar disorder.JNJ-37822681 dihydrochloride is a potent, specific, centrally active, fast-dissociating dopamine D2 receptor antagonist with a moderate binding affinity for the dopamine D2